Vaccine raises hope for cocaine addiction therapy

A vaccine helped block the high felt by cocaine users in 38 percent of people who took it, U.S. researchers said on Monday, offering promise of a new approach to treating those addicted to the drug.

The aim is to prevent cocaine’s rewarding effects — the high — in order to reduce cravings that trigger drug relapses.

“The concept works,” Dr. Thomas Kosten of Baylor College of Medicine in Houston, Texas, whose study appears in the Archives of General Psychiatry, said in a statement.

Cocaine molecules on their own are too small to draw the attention of the immune system. To get the body to recognize cocaine, the researchers designed a vaccine that uses a harmless version of the cholera toxin with a few attached cocaine molecules.

When the immune system reacts to the toxin, it makes both cholera and cocaine antibodies.

“These antibodies bind to the cocaine, preventing it from leaving the bloodstream,” Kosten said. An enzyme called cholinesterase breaks down the cocaine and flushes it out of the body.

For the study, Kosten and colleagues studied 94 volunteers — mostly users of crack cocaine, which is a solid, smokable form of the drug — who were on methadone treatment at the Veterans Affairs Connecticut Healthcare System.

Over three months, the participants either got five shots of the vaccine or a placebo injection.

STUDY PLANS

Plans are under way to study the vaccine in many sites.

According to a 2007 National Survey on Drug Use and Health, 35.9 million Americans aged 12 and older reported having used cocaine, and 8.6 million reported having used crack. In 2006, cocaine accounted for about 14 percent of all admissions to drug abuse treatment programs.

Kosten said he plans to tinker with the vaccine to make it more effective. He has already tried a different carrier — a modified version of a meningitis bacterium — supplied by drug firm Merck & Co.

Animal studies showed it produced five times the antibody response as the cholera carrier.

He has used a similar approach on a nicotine vaccine called TA-NIC now being tested in Europe. Both the cocaine and nicotine vaccines are being developed through private equity firm Celtic Pharma.

aVaccine raises, aVaccine raisesHealth, aVaccine raisesHealth Latest, aVaccine raisesHealth Information, aVaccine raises Health information, aVaccine raises Health Photo,aVaccine raisesfor Weight Health photo, aVaccine raises Health Latest, aVaccine raises Health latest, Choreography for Weight  Health Story, aVaccine raises Video, aVaccine raisesvideo, aVaccine raises   Health History, aVaccine raises Health history, aVaccine raisesover Picture, history, aVaccine raises   Asia, aVaccine raises asia, aVaccine raises  Gallery, aVaccine raises for Weight gallery, aVaccine raises  Photo Gallery, aVaccine raises Picture, aVaccine raises picture, aVaccine raises Web, Malaysia Health, web Health, web Health picture, video photo, video surgery, gallery, laparoscopy, virus, flu, drug, video, Health Health, calories, photo, nutrition, health video, symptoms, cancer, medical, beating, diet, physical, Training, organic, gym, blister, exercise, weightloss, surgery, spiritual, eating, tips, skin, operation, bf1,